Hudkræftklinikken.dk ApS: Financial statements 2018
CVR: 38219960
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Hudkræftklinikken.dk ApS (CVR 38219960) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 1,640,026 and a net result of DKK 57,766. Equity in the 2018 report amounted to DKK 3,306,866. The solvency ratio was 98%.
- Gross Profit
- DKK 1,640,026
- Profit/Loss
- DKK 57,766
- Equity
- DKK 3,306,866
- Total Assets
- DKK 3,374,504
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of July 17, 2018, Kent Stevens Larsen has joined the board of directors of Hudkræftklinikken.dk ApS.
On July 17, 2018, the company changed its name from Hudkræftklinikken.dk Anpartsselskab to Hudkræftklinikken.dk ApS.
Hudkræftklinikken.dk ApS has published its interim report for the period November 20, 2016 to December 31, 2017.
About Hudkræftklinikken.dk ApS
Hudkræftklinikken.dk ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2016. The company is registered under the industry Speciallægers aktiviteter. The company was previously named Hudkræftklinikken.dk Anpartsselskab. The management consists of Bolette Birch Bengtsen. The board consists of Robert Birger Birch (chair), Kent Stevens Larsen and Martin Glud. The company's owners include Birch Bengtsen Invest ApS, PHOENIX CAPITAL ApS and M.Glud holding ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 1,898,097 and a net result of DKK -210,331 compared with DKK 9,266 the year before. Equity in the 2025 report amounted to DKK 757,000.